当前位置: X-MOL 学术Am. J. Hematol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment
American Journal of Hematology ( IF 12.8 ) Pub Date : 2021-10-28 , DOI: 10.1002/ajh.26390
Xavier Troussard 1, 2 , Elsa Maître 1, 2 , Edouard Cornet 1, 2
Affiliation  

Hairy cell leukemia (HCL) and HCL-like disorders, including HCL variant (HCL-V) and splenic diffuse red pulp lymphoma (SDRPL), are a very heterogeneous group of mature lymphoid B-cell disorders characterized by the identification of hairy cells, a specific genetic profile, a different clinical course, and the need for appropriate treatment.

中文翻译:

毛细胞白血病 2022:诊断、风险分层和治疗的最新进展

毛细胞白血病 (HCL) 和 HCL 样疾病,包括 HCL 变异型 (HCL-V) 和脾脏弥漫性红髓淋巴瘤 (SDRPL),是一组非常异质的成熟淋巴样 B 细胞疾病,其特征在于识别毛细胞,特定的遗传特征、不同的临床过程以及对适当治疗的需要。
更新日期:2022-01-06
down
wechat
bug